Journal article · 2021
The preferences of women with ovarian cancer for oral versus intravenous recurrence regimens
Gynecologic Oncology, 162(2), 440–446 · Published 28 May 2021 · DOI 10.1016/j.ygyno.2021.05.022
In brief
“The preferences of women with ovarian cancer for oral versus intravenous recurrence regimens” is a 2021 journal article by Laura Jean Havrilesky and 7 co-authors, published in Gynecologic Oncology. OpenAlex counts 6 citations as of 22 November 2026. The publisher's version is not open access, and OpenAlex records no free legal copy.
- Citations
- 6
- Most cited in
- 2025 (3)
- Field-weighted impact
- 0.27
- References
- 24
- Authors
- 8
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
Havrilesky, L. J., Scott, A. L., Davidson, B. A., Secord, A. A., Yang, J., Johnson, F. R., González, J. M., & Reed, S. D. (2021). The preferences of women with ovarian cancer for oral versus intravenous recurrence regimens. Gynecologic Oncology, 162(2), 440–446. https://doi.org/10.1016/j.ygyno.2021.05.022
MLA 9
Havrilesky, Laura Jean, et al. “The preferences of women with ovarian cancer for oral versus intravenous recurrence regimens.” Gynecologic Oncology, vol. 162, no. 2, 2021, pp. 440–446. https://doi.org/10.1016/j.ygyno.2021.05.022.
Chicago
Havrilesky, Laura Jean, Amelia L. Scott, Brittany Anne Davidson, Angeles Alvarez Secord, Jui‐Chen Yang, F. Reed Johnson, Juan Marcos González, and Shelby D. Reed. 2021. “The preferences of women with ovarian cancer for oral versus intravenous recurrence regimens.” Gynecologic Oncology 162 (2): 440–446. https://doi.org/10.1016/j.ygyno.2021.05.022.
Harvard
Havrilesky, L. J. et al. (2021) ‘The preferences of women with ovarian cancer for oral versus intravenous recurrence regimens’, Gynecologic Oncology, 162(2), pp. 440–446. doi:10.1016/j.ygyno.2021.05.022.
IEEE
L. J. Havrilesky et al., “The preferences of women with ovarian cancer for oral versus intravenous recurrence regimens,” Gynecologic Oncology, vol. 162, no. 2, pp. 440–446, 2021, doi: 10.1016/j.ygyno.2021.05.022.
BibTeX
@article{havrilesky2021preferences,
title = {{The preferences of women with ovarian cancer for oral versus intravenous recurrence regimens}},
author = {Havrilesky, Laura Jean and Scott, Amelia L. and Davidson, Brittany Anne and Secord, Angeles Alvarez and Yang, Jui‐Chen and Johnson, F. Reed and González, Juan Marcos and Reed, Shelby D.},
journal = {Gynecologic Oncology},
year = {2021},
volume = {162},
number = {2},
pages = {440--446},
doi = {10.1016/j.ygyno.2021.05.022},
url = {https://doi.org/10.1016/j.ygyno.2021.05.022}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Citations by year
| Year | Citations | Share of the best year |
|---|---|---|
| 2021 | 1 | |
| 2023 | 1 | |
| 2024 | 1 | |
| 2025 | 3 |
Its field-weighted citation impact is 0.27: it has been cited 0.27 times as often as the average work of the same field, type and year (1.00 is the world average).
Topic and keywords
Health Sciences › Medicine › Oncology › PARP inhibition in cancer therapy
- ovarian cancer
- treatment preferences
- oral chemotherapy
- intravenous chemotherapy
- PARP inhibitors
- platinum-resistant disease
- progression-free survival
- adverse effects
Work with this paper
Most-cited papers in Medicine
- Yaşlı Kadınlarda Üreme SağlığıDemet Kokanalı, Yaprak Engin Üstün · Jinekoloji-Obstetrik ve Neonatoloji Tıp Dergisi · 2019 · 169,630 citations
- Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 CountriesHyuna Sung, Adalberto M. Filho, Mathieu Laversanne and 5 more · CA A Cancer Journal for Clinicians · 2021 · 119,885 citations
- “Mini-mental state”Marshal F. Folstein, Susan E. Folstein, Paul R. McHugh · Journal of Psychiatric Research · 1975 · 90,424 citations
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countriesFreddie Bray, Jacques Ferlay, Isabelle Soerjomataram and 3 more · CA A Cancer Journal for Clinicians · 2018 · 87,396 citations
- Hallmarks of Cancer: The Next GenerationDouglas Hanahan, Robert A. Weinberg · Cell · 2011 · 69,758 citations
Questions about this paper
How do I cite this paper in APA style?
Havrilesky, L. J., Scott, A. L., Davidson, B. A., Secord, A. A., Yang, J., Johnson, F. R., González, J. M., & Reed, S. D. (2021). The preferences of women with ovarian cancer for oral versus intravenous recurrence regimens. Gynecologic Oncology, 162(2), 440–446. https://doi.org/10.1016/j.ygyno.2021.05.022
How many times has this paper been cited?
6 times, according to OpenAlex on 22 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
OpenAlex records no free legal copy. Check your library's access, the authors' pages or a repository, or ask the corresponding author for a copy.
Who wrote this paper?
Laura Jean Havrilesky, Amelia L. Scott, Brittany Anne Davidson, Angeles Alvarez Secord, Jui‐Chen Yang, F. Reed Johnson, Juan Marcos González, Shelby D. Reed.
What is the DOI of this paper?
10.1016/j.ygyno.2021.05.022, permanently at https://doi.org/10.1016/j.ygyno.2021.05.022. Sign in and open it from this page.
Bibliographic data from OpenAlex (CC0), last checked 22 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.